AR HR1039

Recognizes the first week of May 2022 as Tardive Dyskinesia Awareness Week in Arkansas

Identifies tardive dyskinesia as a movement disorder characterized by random, involuntary, and uncontrolled movements of muscles in the face, trunk, and extremities that can develop months, years, or decades after starting dopamine receptor blocking medications and is often permanent

Notes that an estimated 600,000 Americans suffer from tardive dyskinesia, with one in four patients receiving long-term antipsychotic medication treatment experiencing the disorder

Highlights that the U.S. Food and Drug Administration recently approved two new treatments for tardive dyskinesia and that the American Psychiatric Association recommends heightened awareness and regular screening for the condition

Aligns with tardive dyskinesia awareness recognition observed in many states across the country during the first week of May each year